Paper34012000
Double setback for ASO trials in Huntington disease.
Kingwell K. Nat Rev Drug Discov, 2021. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Double setback for ASO trials in Huntington disease. Papers, record 34012000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34012000
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Huntingtin Protein | Major topic |
| Huntington Disease | Major topic |
| Oligonucleotides, Antisense | Major topic |
| Humans | |
| Treatment Failure |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42714706 | Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42714706 | PubMed |
| 42549268 | Enhancing the detection of HTT1a with neoepitope antibodies in mouse models of Huntington's disease. | Brain Commun | 2026 | https://conductscience.org/library/papers/42549268 | PubMed |
| 42181874 | An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42181874 | PubMed |
| 42091595 | Double strand breaks drive toxicity in a Huntington's disease mouse model with or without somatic expansion. | Nat Commun | 2026 | https://conductscience.org/library/papers/42091595 | PubMed |
| 41622913 | The HTT1a protein initiates HTT aggregation in a knock-in mouse model of Huntington's disease. | Brain | 2026 | https://conductscience.org/library/papers/41622913 | PubMed |
| 41422503 | Repeat-associated non-AUG translation as a common mechanism for the polyGln ataxias. | Cell Rep | 2026 | https://conductscience.org/library/papers/41422503 | PubMed |
| 41213972 | Development of a targeted BioPROTAC degrader selective for misfolded SOD1. | Nat Commun | 2025 | https://conductscience.org/library/papers/41213972 | PubMed |
| 41090155 | Gene and RNA Editing: Revolutionary Approaches to Treating Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41090155 | PubMed |
| 40676294 | Natural products proposed for the management of Huntington's disease (HD): a comprehensive review. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40676294 | PubMed |
| 40656227 | Prospects for improved prevention and treatment of neuropsychiatric disorders: Neuroscience Applied. | Neurosci Appl | 2022 | https://conductscience.org/library/papers/40656227 | PubMed |
| 40574039 | In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574039 | PubMed |
| 40501854 | Double strand breaks drive toxicity in Huntington's disease mice with or without somatic expansion. | bioRxiv | 2025 | https://conductscience.org/library/papers/40501854 | PubMed |
| 40499536 | The cell-surface shared proteome of astrocytes and neurons and the molecular foundations of their multicellular interactions. | Neuron | 2025 | https://conductscience.org/library/papers/40499536 | PubMed |
| 40455873 | The parasagittal dural space of the human brain. | Brain | 2025 | https://conductscience.org/library/papers/40455873 | PubMed |
| 40234398 | Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress. | Nat Commun | 2025 | https://conductscience.org/library/papers/40234398 | PubMed |
| 40102650 | Errors in the Huntington's disease gene accumulate slowly and then all at once. | Nature | 2025 | https://conductscience.org/library/papers/40102650 | PubMed |
| 39881338 | Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/39881338 | PubMed |
| 39862873 | Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease. | Lancet Neurol | 2025 | https://conductscience.org/library/papers/39862873 | PubMed |
| 39824182 | Long somatic DNA-repeat expansion drives neurodegeneration in Huntington's disease. | Cell | 2025 | https://conductscience.org/library/papers/39824182 | PubMed |
| 39789319 | RNA dysregulation in neurodegenerative diseases. | EMBO J | 2025 | https://conductscience.org/library/papers/39789319 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34012000
GET https://conductscience.org/api/papers/v1/34012000/cited_by?page=2